These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9666177)

  • 1. Antifungal activities of rapamycin and its derivatives, prolylrapamycin, 32-desmethylrapamycin, and 32-desmethoxyrapamycin.
    Wong GK; Griffith S; Kojima I; Demain AL
    J Antibiot (Tokyo); 1998 May; 51(5):487-91. PubMed ID: 9666177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant improvement of antifungal activity of polyene macrolides by bisalkylation of the mycosamine.
    Paquet V; Carreira EM
    Org Lett; 2006 Apr; 8(9):1807-9. PubMed ID: 16623556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polyene macrolide antibiotics.
    Kerridge D
    Postgrad Med J; 1979 Sep; 55(647):653-6. PubMed ID: 392481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of a new polyene, SPA-S-843, against yeasts.
    Rimaroli C; Bruzzese T
    Antimicrob Agents Chemother; 1998 Nov; 42(11):3012-3. PubMed ID: 9797244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts.
    Hamilton-Miller JM
    Sabouraudia; 1972 Nov; 10(3):276-83. PubMed ID: 4565443
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemical modification and biological evaluation of new semisynthetic derivatives of 28,29-Didehydronystatin A1 (S44HP), a genetically engineered antifungal polyene macrolide antibiotic.
    Preobrazhenskaya MN; Olsufyeva EN; Solovieva SE; Tevyashova AN; Reznikova MI; Luzikov YN; Terekhova LP; Trenin AS; Galatenko OA; Treshalin ID; Mirchink EP; Bukhman VM; Sletta H; Zotchev SB
    J Med Chem; 2009 Jan; 52(1):189-96. PubMed ID: 19055412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].
    Xu Y; Pang GR; Lü XF; Chen ZJ; Sun ST; Song JZ
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro effects of interferon-gamma, alone or in combination with amphotericin B, tested against the pathogenic fungi Candida albicans and Aspergillus fumigatus.
    El-Khoury M; Ligot R; Mahoney S; Stack CM; Perrone GG; Morton CO
    BMC Res Notes; 2017 Aug; 10(1):364. PubMed ID: 28764751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.
    Sehgal SN; Baker H; Vézina C
    J Antibiot (Tokyo); 1975 Oct; 28(10):727-32. PubMed ID: 1102509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of (4-aminobutyloxy)quinolines as a novel class of antifungal agents.
    Vandekerckhove S; Tran HG; Desmet T; D'hooghe M
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4641-3. PubMed ID: 23838261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro biological properties of novel cationic derivatives of amphotericin B.
    Paquet V; Volmer AA; Carreira EM
    Chemistry; 2008; 14(8):2465-81. PubMed ID: 18196508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
    Kubo I; Muroi H; Himejima M
    J Nat Prod; 1993 Feb; 56(2):220-6. PubMed ID: 8463795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MAP kinase-activated protein kinase Rck2p plays a role in rapamycin sensitivity in Saccharomyces cerevisiae and Candida albicans.
    Li X; Huang X; Zhao J; Zhao J; Wei Y; Jiang L
    FEMS Yeast Res; 2008 Aug; 8(5):715-24. PubMed ID: 18625027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B.
    Meunier F; Lambert C; Van der Auwera P
    J Antimicrob Chemother; 1989 Sep; 24(3):325-31. PubMed ID: 2681118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticandidal activity of SPA-S-843, a new polyenic drug.
    Strippoli V; D'Auria FD; Simonetti G; Bruzzese T; Simonetti N
    J Antimicrob Chemother; 2000 Feb; 45(2):235-7. PubMed ID: 10660508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sceliphrolactam, a polyene macrocyclic lactam from a wasp-associated Streptomyces sp.
    Oh DC; Poulsen M; Currie CR; Clardy J
    Org Lett; 2011 Feb; 13(4):752-5. PubMed ID: 21247188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal effects of aminosulphoxide and disulphide derivatives.
    Wittebolle V; Lemriss S; La Morella G; Errante J; Boiron P; Barret R; Sarciron ME
    Mycoses; 2006 May; 49(3):169-75. PubMed ID: 16681806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the cultivation conditions of Candida species yeast-like fungi on their sensitivity to levorin].
    Vasil'eva NG; Fradkova TA; Golubkova LS
    Antibiotiki; 1977 May; 22(5):433-7. PubMed ID: 327914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibitory action of ebselen on fluconazole-resistant Candida albicans: role of the plasma membrane H+-ATPase.
    Billack B; Santoro M; Lau-Cam C
    Microb Drug Resist; 2009 Jun; 15(2):77-83. PubMed ID: 19432523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: a multicenter study.
    Jessup C; Reyes G; Fothergill A; McCarthy D; Rinaldi M; Messer S; Pfaller M; Ghannoum M
    J Chemother; 2000 Feb; 12(1):22-9. PubMed ID: 10768512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.